Listed by the USPTO as WILLIAMS, KEITH RICHARD
Tech Center 1600 • Art Units: 1662 1663
This examiner grants 50% of resolved cases
WILLIAMS, KEITH RICHARD is assigned to tech center 1600 and art unit 1662. The profile contains 14 resolved cases, with an allowance rate of 50.0%. The interview lift is 0.0%, and median time to allowance is 922 days.
The listed companies are Pioneer Hi-bred International Inc., Syngenta AG, and Yeda Research and Development Co. Ltd. The firms are DENTONS US LLP, Knobbe, Martens, Olson & Bear, LLP, and MCKEE, VOORHEES & SEASE, P.L.C. The limited record offers a focused indication of outcomes, but it should not be treated as a broad prediction of future examination behavior.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18851662 | URIDINE DIPHOSPHATE-GLYCOSYLTRANSFERASE AND A TRANSGENIC CELL, TISSUE, AND ORGANISM COMPRISING SAME | Non-Final OA | YEDA RESEARCH AND DEVELOPMENT CO. LTD. |
| 18845798 | TRANSGENIC HELICHRYSUM UMBRACULIGERUM CELL, TISSUE, OR PLANT | Non-Final OA | YEDA RESEARCH AND DEVELOPMENT CO. LTD. |
| 18313288 | B3 TRANSCRIPTION FACTOR GENE FOR SIMULTANEOUSLY IMPROVING LENGTH, STRENGTH AND ELONGATION OF COTTON FIBERS AND USE THEREOF | Non-Final OA | ZHEJIANG UNIVERSITY |
| 18862192 | CONFERRING CYTOPLASMIC MALE STERILITY | Non-Final OA | Syngenta Crop Protection AG |
| 18041274 | WIDE CROSS BREEDING | Non-Final OA | Syngenta Crop Protection AG |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy50.0% of resolved applications examined by Keith Richard Williams were allowed (14 resolved cases), compared with 63.0% across Art Unit 1662 over the last five years.
This examiner's interview lift is +0.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Keith Richard Williams took 922 days on average from filing to allowance.
Keith Richard Williams examines applications in Art Unit 1662 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
